Metformin or α-Lipoic Acid Attenuate Inflammatory Response and NLRP3 Inflammasome in BV-2 Microglial Cells |
Choi, Hye-Rim
(Department of Biomedical Laboratory Science, Konyang University)
Ha, Ji Sun (Department of Biomedical Laboratory Science, Konyang University) Kim, In Sik (Department of Biomedical Laboratory Science, School of Medicine, Eulji University) Yang, Seung-Ju (Department of Biomedical Laboratory Science, Konyang University) |
1 | Tang Y, Le W. Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol Neurobiol. 2016;53:1181-1194. https://doi.org/10.1007/s12035-014-9070-5 DOI |
2 | Paudel YN, Angelopoulou E, Piperi C, Othman I, Aamir K, Shaikh M. Impact of HMGB1, RAGE, and TLR4 in Alzheimer's Disease (AD): From Risk Factors to Therapeutic Targeting. Cells. 2020;9:383. https://doi.org/10.3390/cells9020383 DOI |
3 | Cristovao JS, Gomes CM. S100 proteins in Alzheimer's Disease. Front Neurosci. 2019;13:463. https://doi.org/10.3389/fnins.2019.00463 DOI |
4 | Lee EO, Yang JH, Chang K-A, Suh Y-H, Chong YH. Amyloid- peptide-induced extracellular S100A9 depletion is associated with decrease of antimicrobial peptide activity in human THP-1 monocytes. J Neuroinflammation. 2013;10:1-11. https://doi.org/10.1186/1742-2094-10-68 |
5 | Wang C, Klechikov AG, Gharibyan AL, Warmlander SK, Jarvet J, Zhao L, et al. The role of pro-inflammatory S100A9 in Alzheimer's disease amyloid-neuroinflammatory cascade. Acta Neuropathol. 2014;127:507-522. https://doi.org/10.1007/s00401-013-1208-4 DOI |
6 | Liu Z, Li T, Li P, Wei N, Zhao Z, Liang H, et al. The ambiguous relationship of oxidative stress, tau hyperphosphorylation, and autophagy dysfunction in Alzheimer's disease. Oxid Med Cell Longev. 2015;2015:1-12. https://doi.org/10.1155/2015/352723 |
7 | Son SM, Shin HJ, Byun J, Kook SY, Moon M, Chang YJ, et al. Metformin facilitates amyloid- generation by -and -secretases via autophagy activation. J Alzheimer's Dis. 2016;51:1197-1208. https://doi.org/10.3233/jad-151200 DOI |
8 | Maczurek A, Hager K, Kenklies M, Sharman M, Martins R, Engel J, et al. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. Adv Drug Delivery Rev. 2008;60:1463-1470. https://doi.org/10.1016/j.addr.2008.04.015 DOI |
9 | Jo EK, Kim JK, Shin DM, Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 2016;13:148-159. https://doi.org/10.1038/cmi.2015.95 DOI |
10 | Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019;20:3328. https://doi.org/10.3390/ijms20133328 DOI |
11 | Kim IS, Lee JS. S100A8 and S100A9 secreted by allergens in monocytes inhibit spontaneous apoptosis of normal and asthmatic neutrophils via the Lyn/akt/ERK pathway. Korean J Clin Lab Sci. 2017;49:128-134. https://doi.org/10.15324/kjcls.2017.49.2.128 DOI |
12 | Ha JS, Yeom YS, Jang JH, Kim YH, Im JI, Kim IS, et al. Anti-inflammatory effects of metformin on neuro-inflammation and NLRP3 Inflammasome activation in BV-2 microglial cells. Biomedical Science Letters. 2019;25:92-98. https://doi.org/10.15616/bsl.2019.25.1.92 DOI |
13 | Kim SM, Ha JS, Han AR, Cho S-W, Yang S-J. Effects of -lipoic acid on LPS-induced neuroinflammation and NLRP3 inflammasome activation through the regulation of BV-2 microglial cells activation. BMB reports. 2019;52:613. https://doi.org/10.5483/bmbrep.2019.52.10.026 DOI |
14 | Wang WY, Tan MS, Yu JT, Tan L. Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease. Annals of translational medicine. 2015;3:136. http://doi.org/10.3978/j.issn.2305-5839.2015.03.49 |
15 | Browne TC, McQuillan K, McManus RM, O'Reilly J-A, Mills KH, Lynch MA. IFN- Production by Amyloid -Specific Th1 Cells Promotes Microglial Activation and Increases Plaque Burden in a Mouse Model of Alzheimer's Disease. J Immunol. 2013;190: 2241-2251. https://doi.org/10.4049/jimmunol.1200947 DOI |
16 | Wang S, Song R, Wang Z, Jing Z, Wang S, Ma J. S100A8/A9 in Inflammation. Front Immunol. 2018;9:1298. https://doi.org/10.3389/fimmu.2018.01298 DOI |
17 | Zhan X, Stamova B, Sharp FR. Lipopolysaccharide associates with amyloid plaques, neurons and oligodendrocytes in Alzheimer's disease brain: a review. Front Aging Neurosci. 2018;10:42. https://doi.org/10.3389/fnagi.2018.00042 DOI |
18 | Zhang C, Liu Y, Gilthorpe J, Van der Maarel JR. MRP14 (S100A9) protein interacts with Alzheimer beta-amyloid peptide and induces its fibrillization. PLoS One. 2012;7:e32953. https://doi. org/10.1371/journal.pone.0032953 DOI |
19 | Simard JC, Cesaro A, Chapeton-Montes J, Tardif M, Antoine F, Girard D, et al. S100A8 and S100A9 induce cytokine expression and regulate the NLRP3 inflammasome via ROS-dependent activation of NF- 1. PloS One. 2013;8:e72138. https://doi.org/10.1371/journal.pone.0072138 DOI |
20 | Rotermund C, Machetanz G, Fitzgerald JC. The therapeutic potential of metformin in neurodegenerative diseases. Frontiers in endocrinology. 2018;9:400. https://doi.org/10.3389/fendo.2018.00400 DOI |
21 | Seifar F, Khalili M, Khaledyan H, Amiri Moghadam S, Izadi A, Azimi A, et al. -Lipoic acid, functional fatty acid, as a novel therapeutic alternative for central nervous system diseases: A review. Nutr Neurosci. 2019;22:306-316. https://doi.org/10.1080/1028415x.2017.1386755 DOI |
22 | Uddin M, Stachowiak A, Mamun AA, Tzvetkov NT, Takeda S, Atanasov AG, et al. Autophagy and Alzheimer's disease: from molecular mechanisms to therapeutic implications. Front Aging Neurosci. 2018;10:4. https://doi.org/10.3389/fnagi.2018.00004 DOI |
23 | Wojsiat J, Zoltowska KM, Laskowska-Kaszub K, Wojda U. Oxidant/antioxidant imbalance in Alzheimer's disease: therapeutic and diagnostic prospects. Oxid Med Cell Longev. 2018;2018:1-16. https://doi.org/10.1155/2018/6435861 |
24 | Orihuela R, McPherson CA, Harry GJ. Microglial M1/M2 polarization and metabolic states. British J Pharmacol. 2016;173:649-665. https://doi.org/10.1111/bph.13139 DOI |
25 | Tonnies E, Trushina E. Oxidative stress, synaptic dysfunction, and Alzheimer's disease. J Alzheimer Dis. 2017;57:1105-1121. https://doi.org/10.3233/jad-161088 DOI |
26 | Cho MH, Cho K, Kang HJ, Jeon EY, Kim HS, Kwon HJ, et al. Autophagy in microglia degrades extracellular -amyloid fibrils and regulates the NLRP3 inflammasome. Autophagy. 2014;10:1761-1775. https://doi.org/10.4161/auto.29647 DOI |
27 | He Y, Hara H, Nunez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci. 2016;41:1012-1021. https://doi.org/10.1016/j.tibs.2016.09.002 DOI |
28 | Cui W, Sun C, Ma Y, Wang S, Wang X, Zhang Y. Inhibition of TLR4 induces M2 microglial polarization and provides neuroprotection via the NLRP3 inflammasome in Alzheimer's disease. Front Neurosci. 2020;14. https://doi.org/10.3389/fnins.2020.00444 |
29 | Solito E, Sastre M. Microglia function in Alzheimer's disease. Front pharmacol. 2012;3:14. https://doi.org/10.3389/fphar.2012.00014 DOI |
30 | Rajmohan R, Reddy PH. Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer's disease neurons. J Alzheimer's Dis. 2017;57:975-999. https://doi.org/10.3233/jad-160612 DOI |